🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to share Symphony, our method for single-cell reference mapping, out now in Nature Communications 🎉: nature.com/articles/s4146… Ilya Korsunsky Soumya Raychaudhuri সৌম্য রায়চৌধুরী

Now watching Andrea Fava speaking on biomarkers in lupus nephritis! 8M114 🚨 87% of repeat kidney bx lead to change in Rx 🚨 👉🏽 biopsies have their own limitations 👉🏽 urinary biomarkers may reflect ts bx (liquid biopsy) ✴️urin CD163 ⬆️⬆️ in prolif LN✴️ #ACR21 #ACRAmbassador

Hard to keep up with all the good news. Congrats to Philip Seo, Program Director extraordinaire and Director of the Johns Hopkins Vasculitis Clinic, for receiving the ACR Distinguished Clinician Scholar Award. #ACR21 Johns Hopkins Medicine Hopkins Med News

Follow some of our Johns Hopkins rheumatologists on Twitter: Brit Adler @cappelliMD LisaChristopherStine Julie J. Paik Myma Albayda, MD, RhMSUS Andrea Fava Philip Seo Max Konig #ACR21 #RheumTwitter #rheumatology Johns Hopkins Medicine

IL-16 is linked to lupus nephritis activity: a novel biomarker and potential therapeutic target discovered by the Accelerating Medicines Partnership! doi.org/10.1002/art.42… Soumya Raychaudhuri সৌম্য রায়চৌধুরী Deepak Rao Hopkins Med News Johns Hopkins Rheumatology Dr. John Cush NIAMS Lupus Foundation of America Lupus Research

#Hiring Join our research Hopkins Rheumatology to discover new treatments and molecularly redefine kidney #lupus using many omics? Computational only or hybrid with wet lab experience. Fun guaranteed. Physician-scientists most welcome. T32. DM me! Lupus Foundation of America Rheumatology Research Foundation

Find out about recent efforts to deliver more targeted & effective #rheum treatments during a session at #ACR22. Read a preview in ACR Convergence Today → acr.tw/3fVs8Fw Andrea Fava

Kicking us off this morning: Many of our Johns Hopkins Medicine rheumatologists are presenting during the #ACR22 virtual and in-person poster sessions starting at 9am. Join Brit Adler Andrea Fava Zsuzsanna McMahan Caoilfhionn Connolly and others.

‼️ Application Opening ‼️ Join us as a postdoc #T32 research fellow in the Division of #Rheumatology! Learn more: hopkinsrheumatology.org/T32

CONGRESS #EULAR2023 | Andrea Fava presented data on urinary biomarker levels at 3 months predicting treatment response at 12 months. CD206, CD163 and IL16 better predict treatment response in proliferative LN than proteinuria. #Lupus #lupusnephritis

Honoured to receive this award! Huge thanks to Lupus Academy for the opportunity and gratitude to my mentor Andrea Fava for guiding me every step of the journey! 🙏🏻#grateful #AwardWinning

Wonderful presentation by Alessandra Ida Celia on a possibly novel cell type implicated in lupus nephritis #ACR23 #ACRBest

Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis: buff.ly/48JqcGg Andrea Fava Johns Hopkins Medicine #Nephrology

Low urinary IL16 levels at 12 months predicts kidney survival at 3 years better than proteinuria - @Andreafava @rheumnow #RNL2024 buff.ly/3UEdOmc

Tomorrow #preprintHub1 Nicolas Ruffin from Karolinska Institutet will present a #preprint by Luigi Adamo lab showing how B cell-mediated antigen presentation promotes adverse cardiac remodelling in chronic heart failure 🫀🩺👷‍♀️ biorxiv.org/content/10.110…

268/279 SLE pts w/ kidney biopsy for proteinuria were Dx w/ lupus nephritis. Proliferative LN (III/IV+V) had higher levels of C1q, chromatin, dsDNA, ribosomal P Abs. C1q & dsDNA independently assoc w/ proliferative LN. AutoAbs decreased in proliferative LN buff.ly/4cCQCvf

Levels of anti-C1q and anti-dsDNA were independently associated with proliferative lupus nephritis In proliferative LN, higher baseline anti-C1q levels predicted complete response better than baseline proteinuria In A&R loom.ly/OXIzDVI

Yoo Jin Kim led our Johns Hopkins Cardiology + Andrea Fava Hopkins Rheumatology team in investigating recurrent pericarditis in Lupus. Oral prednisone therapy increased recurrence risk. Further evidence that prednisone should be minimized in lupus?⁦JAMA Network Open⁩ jamanetwork.com/journals/jaman…